{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:14:55Z","timestamp":1794266095882,"version":"4.9.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T00:00:00Z","timestamp":1475107200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s12015-016-9683-3","type":"journal-article","created":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T01:29:47Z","timestamp":1475112587000},"page":"645-653","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation in Hepatitis B Virus Related Acute-on-Chronic Liver Failure Treated with Plasma Exchange and Entecavir: a 24-Month Prospective Study"],"prefix":"10.1007","volume":"12","author":[{"given":"Yu-Hua","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Mei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Yue-Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,29]]},"reference":[{"key":"9683_CR1","first-page":"655","volume":"26","author":"XF Liang","year":"2005","unstructured":"Liang, X. F., Chen, Y. S., Wang, X. J., et al. (2005). A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old [in Chinese. Zhonghua Liu Xing Bing Xue Za Zhi, 26, 655\u2013658.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"4","key":"9683_CR2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12072-014-9580-2","volume":"8","author":"SK Sarin","year":"2014","unstructured":"Sarin, S. K., Kedarisetty, C. K., Abbas, Z., et al. (2014). APASL ACLF working party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL) 2014. Hepatology International, 8(4), 453\u2013471.","journal-title":"Hepatology International"},{"key":"9683_CR3","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/hep.20704","volume":"41","author":"KF Murray","year":"2005","unstructured":"Murray, K. F., & Carithers, R. L. A. A. S. L. D. (2005). Practice guidelines: evaluation of the patient for liver transplantation. Hepatology, 41, 1407\u20131432.","journal-title":"Hepatology"},{"issue":"Suppl 2","key":"9683_CR4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s12072-014-9534-8","volume":"8","author":"R Maiwall","year":"2014","unstructured":"Maiwall, R., Maras, J. S., Nayak, S. L., et al. (2014). Liver dialysis in acute-on-chronic liver failure: current and future perspectives. Hepatology International, 8(Suppl 2), 505\u2013513.","journal-title":"Hepatology International"},{"issue":"1","key":"9683_CR5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2015.08.018","volume":"64","author":"FS Larsen","year":"2015","unstructured":"Larsen, F. S., Schmidt, L. E., Bernsmeier, C., et al. (2015). High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. Journal of Hepatology, 64(1), 69\u201378.","journal-title":"Journal of Hepatology"},{"issue":"3","key":"9683_CR6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s12072-015-9667-4","volume":"10","author":"W Yue-Meng","year":"2016","unstructured":"Yue-Meng, W., Yang, L. H., Yang, J. H., et al. (2016). The effect of plasma exchange on entecavir-treated chronic hepatitis B patients with hepatic de-compensation and acute-onchronic liver failure. Hepatology International, 10(3), 462\u2013469.","journal-title":"Hepatology International"},{"key":"9683_CR7","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/hep.20469","volume":"40","author":"KD Lee","year":"2004","unstructured":"Lee, K. D., Kuo, T. K., Whang-Peng, J., et al. (2004). In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology, 40, 1275\u20131284.","journal-title":"Hepatology"},{"key":"9683_CR8","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1634\/stemcells.2005-0542","volume":"24","author":"S Terai","year":"2006","unstructured":"Terai, S., Ishikawa, T., Omori, K., et al. (2006). Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells, 24, 2292\u20132298.","journal-title":"Stem Cells"},{"key":"9683_CR9","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/MEG.0b013e32832a1f6c","volume":"21","author":"P Kharaziha","year":"2009","unstructured":"Kharaziha, P., Hellstr\u00f6m, P. M., Noorinayer, B., et al. (2009). Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. European Journal of Gastroenterology & Hepatology, 21, 1199\u20131205.","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"suppl 2","key":"9683_CR10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1440-1746.2011.07024.x","volume":"27","author":"Z Zhang","year":"2012","unstructured":"Zhang, Z., Lin, H., Shi, M., et al. (2012). Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. Journal of Gastroenterology and Hepatology, 27(suppl 2), 112\u2013120.","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"10","key":"9683_CR11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.5966\/sctm.2012-0034","volume":"1","author":"M Shi","year":"2012","unstructured":"Shi, M., Zhang, Z., Xu, R., et al. (2012). Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Translational Medicine, 1(10), 725\u2013731.","journal-title":"Stem Cells Translational Medicine"},{"issue":"3","key":"9683_CR12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/hep.24434","volume":"54","author":"P Liang","year":"2011","unstructured":"Liang, P., Xie, D.-y., Lin, B.-L., et al. (2011). Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology, 54(3), 820\u2013828.","journal-title":"Hepatology"},{"key":"9683_CR13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","volume":"3","author":"SK Sarin","year":"2009","unstructured":"Sarin, S. K., Kumar, A., Almeida, J. A., et al. (2009). Acute-onchronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL. Hepatology International, 3, 269\u2013282.","journal-title":"Hepatology International"},{"key":"9683_CR14","unstructured":"Yue-Meng, W., Li, Y. H., Wu, H. M., et al. (2016) Telbivudine versus lamivudine and entecavir fortreatment-na\u00efve decompensated hepatitis B virus-relatedcirrhosis. Clinical and Experimental Medicine 19 Apr 2016"},{"key":"9683_CR15","first-page":"1017","volume":"91","author":"L LL","year":"2006","unstructured":"LL, L., Liu, Y. J., Yang, S. G., et al. (2006). Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica, 91, 1017\u20131026.","journal-title":"Haematologica"},{"key":"9683_CR16","doi-asserted-by":"crossref","unstructured":"Kamath, P. S., & Kim, W. R. (2007). The model for end-stage liver disease (MELD). Hepatology, 45(3), 797\u2013805.","DOI":"10.1002\/hep.21563"},{"key":"9683_CR17","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1136\/gut.2004.062208","volume":"54","author":"HJ Flink","year":"2005","unstructured":"Flink, H. J., Sprengers, D., Hansen, B. E., et al. (2005). HBV 99-01 study group. Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during peg-interferon alpha-2b therapy. Gut, 54, 1604\u20131609.","journal-title":"Gut"},{"issue":"7","key":"9683_CR18","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","volume":"144","author":"R Moreau","year":"2013","unstructured":"Moreau, R., Jalan, R., Gines, P., et al. (2013). Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology, 144(7), 1426\u20131437.","journal-title":"Gastroenterology"},{"issue":"1","key":"9683_CR19","doi-asserted-by":"crossref","first-page":"e54773","DOI":"10.1371\/journal.pone.0054773","volume":"8","author":"F Xie","year":"2013","unstructured":"Xie, F., Yan, L., Lu, J., et al. (2013). Effects of nucleoside analogue on patients with chronic hepatitis B-associated liver failure: meta-analysis. PloS One, 8(1), e54773.","journal-title":"PloS One"},{"key":"9683_CR20","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa051285","volume":"354","author":"TT Chang","year":"2006","unstructured":"Chang, T. T., Gish, R. G., de Man, R., et al. (2006). A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. The New England Journal of Medicine, 354, 1001\u20131010.","journal-title":"The New England Journal of Medicine"},{"key":"9683_CR21","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa051287","volume":"354","author":"CL Lai","year":"2006","unstructured":"Lai, C. L., Shouval, D., Lok, A. S., et al. (2006). Entecavir versus lamivudine for patients with HBeAg negative chronic hepatitis B. The New England Journal of Medicine, 354, 1011\u20131020.","journal-title":"The New England Journal of Medicine"},{"key":"9683_CR22","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/hep.22841","volume":"49","author":"DJ Tenney","year":"2009","unstructured":"Tenney, D. J., Rose, R. E., Baldick, C. J., et al. (2009). Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naive patients is rare through 5\u00a0years of therapy. Hepatology, 49, 1503\u20131514.","journal-title":"Hepatology"},{"key":"9683_CR23","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.23346","volume":"50","author":"CM Lange","year":"2009","unstructured":"Lange, C. M., Bojunga, J., Hofmann, W. P., et al. (2009). Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function. Hepatology, 50, 2001\u20132006.","journal-title":"Hepatology"},{"issue":"4","key":"9683_CR24","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1499-3872(15)60338-1","volume":"14","author":"XY Liu","year":"2015","unstructured":"Liu, X. Y., Peng, F., Pan, Y. J., et al. (2015). Advanced therapeutic strategies for HBV-related acute-on-chronic liver failure. Hepatobiliary & Pancreatic Diseases International, 14(4), 354\u2013360.","journal-title":"Hepatobiliary & Pancreatic Diseases International"},{"key":"9683_CR25","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3892\/etm.2013.1241","volume":"6","author":"Z Zheng","year":"2013","unstructured":"Zheng, Z., Li, X., Li, Z., et al. (2013). Artificial and bioartificial liver support systems for acute and acute-on-chronic hepatic failure: a meta-analysis and meta-regression. Experimental and Therapeutic Medicine, 6, 929\u2013936.","journal-title":"Experimental and Therapeutic Medicine"},{"key":"9683_CR26","first-page":"65","volume":"109","author":"H Nakae","year":"2001","unstructured":"Nakae, H., Yonekawa, T., Narita, K., et al. (2001). Are proinflammatory cytokine concentrations reduced by plasma exchange in patients with severe acute hepatic failure? Research Communications in Molecular Pathology and Pharmacology, 109, 65\u201372.","journal-title":"Research Communications in Molecular Pathology and Pharmacology"},{"key":"9683_CR27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000014407","volume":"18","author":"T Nakamura","year":"2000","unstructured":"Nakamura, T., Ushiyama, C., Suzuki, S., et al. (2000). Effect of plasma exchange on serum tissue inhibitor of metalloproteinase 1 and cytokine concentrations in patients with fulminant hepatitis. Blood Purification, 18, 50\u201354.","journal-title":"Blood Purification"},{"key":"9683_CR28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1053\/j.gastro.2011.11.027","volume":"142","author":"V Garg","year":"2012","unstructured":"Garg, V., Garg, H., Khan, A., et al. (2012). Granulocyte-colony stimulating factor mobilizes CD34+ cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology, 142, 505\u2013512.","journal-title":"Gastroenterology"},{"issue":"2","key":"9683_CR29","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.transproceed.2014.10.048","volume":"47","author":"HL Xue","year":"2015","unstructured":"Xue, H. L., Zeng, W. Z., XL, W., et al. (2015). Clinical therapeutic effects of human umbilical cord-derived mesenchymal stem cells transplantation in the treatment of end-stage liver disease. Transplantation Proceedings, 47(2), 412\u2013418.","journal-title":"Transplantation Proceedings"},{"key":"9683_CR30","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00441-012-1524-3","volume":"351","author":"X Zhu","year":"2013","unstructured":"Zhu, X., He, B., Zhou, X., et al. (2013). Effects of transplanted bone-marrow-derived mesenchymal stem cells in animal models of acute hepatitis. Cell and Tissue Research, 351, 477\u2013486.","journal-title":"Cell and Tissue Research"},{"key":"9683_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2011.04327.x","volume":"164","author":"M Shi","year":"2011","unstructured":"Shi, M., Liu, Z. W., & Wang, F. S. (2011). Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clinical and Experimental Immunology, 164, 1\u20138.","journal-title":"Clinical and Experimental Immunology"},{"key":"9683_CR32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/gut.2005.090050","volume":"56","author":"I Aurich","year":"2007","unstructured":"Aurich, I., Mueller, L. P., Aurich, H., et al. (2007). Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut, 56, 405\u2013415.","journal-title":"Gut"},{"key":"9683_CR33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/gut.2006.111617","volume":"57","author":"LV Bonzo di","year":"2008","unstructured":"di Bonzo, L. V., Ferrero, I., Cravanzola, C., et al. (2008). Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut, 57, 223\u2013231.","journal-title":"Gut"},{"key":"9683_CR34","doi-asserted-by":"crossref","unstructured":"Baertschiger RM, Serre-Beinier V, Morel P, et al. Fibrogenic potential of human multipotent mesenchymal stromal cells in injured liver. PloS One 2009; 4:e6657.","DOI":"10.1371\/journal.pone.0006657"},{"key":"9683_CR35","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1136\/gut.2008.154880","volume":"58","author":"H Aurich","year":"2009","unstructured":"Aurich, H., Sgodda, M., Kaltwasser, P., et al. (2009). Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut, 58, 570\u2013581.","journal-title":"Gut"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-016-9683-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12015-016-9683-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-016-9683-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T23:06:14Z","timestamp":1568415974000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12015-016-9683-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,29]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["9683"],"URL":"https:\/\/doi.org\/10.1007\/s12015-016-9683-3","relation":{},"ISSN":["1550-8943","1558-6804"],"issn-type":[{"value":"1550-8943","type":"print"},{"value":"1558-6804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,29]]}}}